Elisabeth Bjork

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
4 years
Director since
2023

4 years of board service in total across 2 boards, counting each seat separately. Longest: Rocket Pharmaceuticals Inc., 3 years.

3 years · Since 2023
Pharvaris N.V. Director
7 months · Since 2026

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 17, 2026 Pharvaris N.V. Option exercise +35,000 $14.39 $503,650
Sep 17, 2026 Pharvaris N.V. Option exercise +17,500 $18.14 $317,450
Sep 17, 2026 Pharvaris N.V. Open-market sale −52,500 $37.89 $1,989,225
May 20, 2026 Pharvaris N.V. Option exercise +10,000 $8.05 $80,500
May 20, 2026 Pharvaris N.V. Open-market sale −10,000 $29.32 $293,200
Jan 2, 2026 Rocket Pharmaceuticals Inc. Open-market purchase +10,000 $3.44 $34,400
Aug 27, 2025 Rocket Pharmaceuticals Inc. Open-market purchase +10,000 $3.41 $34,100
Jun 18, 2025 Rocket Pharmaceuticals Inc. Grant or award +30,000 — —

Questions about Elisabeth Bjork

What boards is Elisabeth Bjork on?

Elisabeth Bjork sits on the boards of Pharvaris N.V. and Rocket Pharmaceuticals Inc.

How long has Elisabeth Bjork served on boards?

Our records show at least 4 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.